Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Syndax Pharma (NQ: SNDX )

18.15 USD +0.09 (+0.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 396,604
Open 18.36
Bid (Size) 18.15 (1)
Ask (Size) 20.00 (1)
Prev. Close 18.06
Today's Range 18.00 - 18.74
52wk Range 13.02 - 27.85
Shares Outstanding 48,248,559
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Syndax Announces Participation in Goldman Sachs 42nd Annual Global Healthcare Conference
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that... 
From PR Newswire
Syndax Announces Participation in Cowen 2nd Annual Virtual Oncology Innovation Summit
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that... 
From PR Newswire

Performance

YTD
-18.76%
-18.76%
1 Month
+2.60%
+2.60%
3 Month
-24.09%
-24.09%
6 Month
-25.15%
-25.15%
1 Year
+20.84%
+20.84%

More News

Read More
Syndax Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical and Business Update
From PR Newswire
Syndax to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11, 2021
From PR Newswire
CORRECTION: Biotechs Working on Potential Preventive Measures and Cancer Treatments
From PR Newswire
Syndax Pharmaceuticals: Return On Capital Employed Insights
Tags News SNDX Benzinga
From Benzinga
Return On Capital Employed Overview: Syndax Pharmaceuticals
Tags Market News SNDX BZI/ROCE
From Benzinga
Syndax Pharma Updates On Interim Phase 1 Data From SNDX-5613 Leukemia Trial
Tags SNDX Small Cap Biotech
From Benzinga
Recap: Syndax Pharmaceuticals Q1 Earnings
Tags Market News SNDX BZI/Recaps
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tags SXTC NERV NVIV
From Benzinga
Last Week's Notable Insider Buys: AppLovin, Bed Bath And Beyond, TuSimple And More
Tags Penny Stocks MTEM ARK Invest
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.